Tang Capital Partners acquired a 9.6% stake in Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC). The stock price climbed $1.35 to close at $8.28.
Tang Capital takes stake in Cyclacel Pharmaceuticals
August 22, 2016 at 19:07 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.